KEGG   DISEASE: Nephrotic syndromeHelp
H01657                      Disease                                

Nephrotic syndrome
Nephrotic syndrome is a heterogeneous group of disorders characterized by heavy proteinuria (more than 3.5 grams per day), hypoalbuminemia, hyperlipidemia, and edema. Congenital nephrotic syndrome is most frequently related to mutations in genes specific for structural integrity of the glomerular basement membrane and associated filtration structures within the kidney, resulting in massive leakage of plasma proteins into the urine. First line treatment is with oral corticosteroids, but some patients do not respond to this treatment. Steroid-resistant nephrotic syndrome (SRNS) typically manifests histologically as focal segmental glomerulosclerosis. Calcineurin inhibitors with/without intravenous methylprednisolone pulse therapy (MPT) constitute the standard treatment for SRNS. It has been reported that additional rituximab treatment combined with conventional MPT and immunosuppressive agents is a promising option.
Urinary system disease
Human diseases [BR:br08402]
 Urinary system diseases
  Kidney diseases
   H01657  Nephrotic syndrome
Human diseases in ICD-11 classification [BR:br08403]
 16 Diseases of the genitourinary system
  Diseases of the urinary system
   Glomerular diseases
    GB41  Nephrotic syndrome
     H01657  Nephrotic syndrome
BRITE hierarchy
(NPHS1) NPHS1 [HSA:4868]
(NPHS2) PDCN [HSA:7827] [KO:K18268]
(NPHS3) PLCE1 [HSA:51196] [KO:K05860]
(NPHS4) WT1 [HSA:7490] [KO:K09234]
(NPHS5) LAMB2 [HSA:3913] [KO:K06243]
(NPHS6) PTPRO [HSA:5800] [KO:K18035]
(NPHS7) DGKE [HSA:8526] [KO:K00901]
(NPHS8) ARHGDIA [HSA:396] [KO:K12462]
(NPHS9) COQ8B [HSA:79934] [KO:K08869]
(NPHS10) EMP2 [HSA:2013]
(NPHS11) NUP107 [HSA:57122] [KO:K14301]
(NPHS12) NUP93 [HSA:9688] [KO:K14309]
(NPHS13) NUP205 [HSA:23165] [KO:K14310]
(NPHS14) SGPL1 [HSA:8879] [KO:K01634]
(NPHS15) MAGI2 [HSA:9863] [KO:K05629]
(NPHS16) KANK2 [HSA:25959] [KO:K22808]
Triamcinolone acetonide [DR:D00983]
Dexamethasone [DR:D00292]
Dexamethasone sodium phosphate [DR:D00975]
Hydrocortisone [DR:D00088]
Hydrocortisone sodium succinate [DR:D00978]
Prednisolone [DR:D00472]
Prednisolone sodium phosphate [DR:D00981]
Chlorothiazide sodium [DR:D03471]
Chlorthalidone [DR:D00272]
Metolazone [DR:D00431]
Bumetanide [DR:D00247]
Ethacrynic acid [DR:D00313]
Spironolactone [DR:D00443]
Spironolactone and hydrochlorothiazide [DR:D10270]
Methylprednisolone [DR:D00407]
Corticotropin [DR:D00146]
Cyclophosphamide [DR:D00287]
Other DBs
ICD-11: GB41
ICD-10: N04
MeSH: D009404
OMIM: 256300 600995 610725 256370 614199 614196 615008 615244 615573 615861 616730 616892 616893 617575 617609 617783
Gubler MC
Nephrotic syndrome: Genetic testing in steroid-resistant nephrotic syndrome.
Nat Rev Nephrol 7:430-1 (2011)
Benoit G, Machuca E, Heidet L, Antignac C
Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes.
Ann N Y Acad Sci 1214:83-98 (2010)
PMID:17537341 (drug)
Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS
The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.
Health Technol Assess 11:iii-iv, ix-xi, 1-93 (2007)
PMID:24500706 (drug)
Kamei K, Okada M, Sato M, Fujimaru T, Ogura M, Nakayama M, Kaito H, Iijima K, Ito S
Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome.
Pediatr Nephrol 29:1181-7 (2014)
Bierzynska A, McCarthy HJ, Soderquest K, Sen ES, Colby E, Ding WY, Nabhan MM, Kerecuk L, Hegde S, Hughes D, Marks S, Feather S, Jones C, Webb NJ, Ognjanovic M, Christian M, Gilbert RD, Sinha MD, Lord GM, Simpson M, Koziell AB, Welsh GI, Saleem MA
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
Kidney Int 91:937-947 (2017)
Janecke AR, Xu R, Steichen-Gersdorf E, Waldegger S, Entenmann A, Giner T, Krainer I, Huber LA, Hess MW, Frishberg Y, Barash H, Tzur S, Schreyer-Shafir N, Sukenik-Halevy R, Zehavi T, Raas-Rothschild A, Mao C, Muller T
Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications.
Hum Mutat 38:365-372 (2017)
Bierzynska A, Soderquest K, Dean P, Colby E, Rollason R, Jones C, Inward CD, McCarthy HJ, Simpson MA, Lord GM, Williams M, Welsh GI, Koziell AB, Saleem MA
MAGI2 Mutations Cause Congenital Nephrotic Syndrome.
J Am Soc Nephrol 28:1614-1621 (2017)
Gee HY, Zhang F, Ashraf S, Kohl S, Sadowski CE, Vega-Warner V, Zhou W, Lovric S, Fang H, Nettleton M, Zhu JY, Hoefele J, Weber LT, Podracka L, Boor A, Fehrenbach H, Innis JW, Washburn J, Levy S, Lifton RP, Otto EA, Han Z, Hildebrandt F
KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
J Clin Invest 125:2375-84 (2015)

» Japanese version

DBGET integrated database retrieval system